• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种伴有骨髓嗜酸性粒细胞增多的骨髓增生异常综合征,最终发展为急性非淋巴细胞白血病,并与16号染色体异常相关。

A myelodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16.

作者信息

Abbondanzo S L, Gray R G, Whang-Peng J, Jacobson R J

出版信息

Arch Pathol Lab Med. 1987 Apr;111(4):330-2.

PMID:3469939
Abstract

A patient presented with a myelodysplastic syndrome and bone marrow eosinophilia that evolved six months later into an acute nonlymphocytic leukemia (ANLL). Cytogenetic analyses of the bone marrow revealed 86% of the metaphases with 45,X-Y,inv(16)(p13;q22),t(11;17) (q11;q25),del(21)(q13) and 14% of the metaphases with the same abnormalities but with a Y chromosome. The association of ANLL, bone marrow eosinophilia, and abnormal chromosome 16 has previously been reported and has been suggested to have a favorable prognosis. Our patient is unique in that ANLL was preceded by a preleukemic phase associated with bone marrow eosinophilia. When complete remission was achieved, the bone marrow cytogenetics returned to normal, and the eosinophilia disappeared.

摘要

一名患者最初表现为骨髓增生异常综合征和骨髓嗜酸性粒细胞增多,6个月后进展为急性非淋巴细胞白血病(ANLL)。对其骨髓进行的细胞遗传学分析显示,86%的中期细胞具有45,X-Y,inv(16)(p13;q22),t(11;17)(q11;q25),del(21)(q13),14%的中期细胞具有相同异常但有Y染色体。ANLL、骨髓嗜酸性粒细胞增多和16号染色体异常的关联此前已有报道,且提示预后良好。我们的患者具有独特性,即ANLL之前存在与骨髓嗜酸性粒细胞增多相关的白血病前期。当实现完全缓解时,骨髓细胞遗传学恢复正常,嗜酸性粒细胞增多消失。

相似文献

1
A myelodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16.一种伴有骨髓嗜酸性粒细胞增多的骨髓增生异常综合征,最终发展为急性非淋巴细胞白血病,并与16号染色体异常相关。
Arch Pathol Lab Med. 1987 Apr;111(4):330-2.
2
Chromosome change at 16q22 in nonlymphocytic leukemia: clinical implication on leukemia patients with inv(16) versus del(16).非淋巴细胞白血病中16q22的染色体改变:inv(16)与del(16)的白血病患者的临床意义
Leukemia. 1988 Jan;2(1):35-40.
3
Acute nonlymphocytic leukemia with marrow eosinophilia and chromosome 16 abnormality: a report of 18 cases.伴有骨髓嗜酸性粒细胞增多和16号染色体异常的急性非淋巴细胞白血病:18例报告
Leukemia. 1989 Oct;3(10):740-5.
4
Sequential observation of clinical and karyotypic evolution in a patient with myelodysplastic syndrome.
Chin Med J (Engl). 1989 Sep;102(9):689-94.
5
Myelodysplastic syndrome that progressed to acute myelomonocytic leukemia with eosinophilia showing peculiar chromosomal abnormality: a case report.骨髓增生异常综合征进展为伴有嗜酸性粒细胞增多的急性粒单核细胞白血病并显示特殊染色体异常:一例报告
J Korean Med Sci. 1999 Aug;14(4):448-50. doi: 10.3346/jkms.1999.14.4.448.
6
A myelodysplastic syndrome with eosinophilia associated with a break in the short arm of chromosome 16.
Leukemia. 1987 Sep;1(9):680-1.
7
Acute myelomonocytic leukemia (M4) with eosinophilia: problems concerning chromosome 16 abnormality.伴嗜酸性粒细胞增多的急性粒单核细胞白血病(M4):关于16号染色体异常的问题。
Cancer Genet Cytogenet. 1986 Oct;23(2):127-33.
8
Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.急性髓系白血病中CD34表达与染色体异常的相关性,但与临床结局无关。
Am J Hematol. 1996 Nov;53(3):175-80. doi: 10.1002/(SICI)1096-8652(199611)53:3<175::AID-AJH5>3.0.CO;2-W.
9
Myelodysplastic syndrome preceding acute myelomonocytic leukemia with dysplastic marrow eosinophilia and inv(16).伴有发育异常性骨髓嗜酸性粒细胞增多和inv(16)的急性粒单核细胞白血病之前的骨髓增生异常综合征
Acta Haematol. 1989;82(3):161-4. doi: 10.1159/000205368.
10
Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.32例骨髓增生异常综合征患者的细胞遗传学研究:对特定染色体异常及预后的见解
Jpn J Clin Oncol. 1987 Jun;17(2):141-50.

引用本文的文献

1
The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia.在髓系白血病中,由inv(16)(p13;q22)产生的PEBP2β-MYH11融合蛋白会损害中性粒细胞成熟,并导致粒细胞发育异常。
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11863-8. doi: 10.1073/pnas.95.20.11863.